Community Oncology
We're investing in the future of community oncology.
When community practices thrive, so does the care for millions of cancer patients. From our earliest days, we have been focused on the long-term success of community oncology.
The leading technology platform in community oncology
Our OncoCloud suite is built to meet the technology needs of the community practice of the future: operationally efficient and prepared to thrive in the world of value-based care.
Over 2,500 clinicians at more than 800 sites across the country have chosen Flatiron as their long-term technology partner.
- The OncoCloud Suite has been ranked the #1 end-to-end oncology technology solution by Black Book Research.
- OncoEMR is top-rated for overall satisfaction by KLAS’ 2019 Medical Oncology Performance Report.
Our OncoCloud™ Suite
MIPS & OCM Support You Deserve
Value-Based Care
Declining reimbursement rates, increased patient loads and regulatory changes are a difficult reality for many clinics. It’s no surprise that so many find it challenging to remain financially viable while delivering the best care possible. Flatiron’s OncoCloud products can help.
Learn more
In our previous system, it took 23 steps to schedule a patient. Now it takes less than half of that.
Our Practices Include:
Let us tell you more.
We will email you to start the conversation.
West Cancer Center Implements Flatiron Revenue Cycle Management
Flatiron Health announced today that West Cancer Center and Research Institute fully implemented their Flatiron Revenue Cycle Management service to optimize their financial performance.
Community Oncology Financial Counselors Get Creative to Help Patients Manage the Cost of Care
Product Operations Manager Ashley Patton on the crucial role of financial counselors in community oncology.
The Physician Visit Note
The physician visit note has always tried to do too many things at once, but as the number of documentation requirements has increased, it has become a dumping ground — a jack of all trades, but a master of none.